Managing Out-of-Control Results in TB EQA Programs
External quality assessment (EQA) is a central way for tuberculosis laboratories to verify testing accuracy, compare performance with peers, and identify weaknesses that internal quality control may not reveal. When an EQA result falls outside the expected range, the finding should be treated as evidence requiring investigation rather than as a reason for blame.
Out-of-control results can arise from technical mistakes, transcription errors, equipment problems, unsuitable reagents, unclear procedures, or weaknesses in specimen handling. A reliable response therefore needs to be structured, documented, and proportionate to the potential risk to patients and public health.
The GLI Quality Tool supports laboratories as they build this response into a broader quality management system. Its roadmap connects EQA review with quality systems essentials such as personnel, equipment, documents and records, assessment, process management, and continual improvement.
Confirm the Result Before Searching for Causes
The first step is to verify that the EQA finding has been interpreted correctly. Review the provider’s report, the assigned or consensus result, the laboratory’s submitted result, the reporting deadline, and any comments about acceptable variation. Check whether the result was marked incorrect, late, incomplete, contaminated, or technically invalid, since these categories may require different actions.
Confirm that the result belongs to the correct panel, test method, instrument, and reporting cycle. A result can appear abnormal because of a transcription mistake, a swapped specimen identifier, or an incorrect result entered on the EQA form. The original worksheet, instrument printout, electronic record, and final submission should be compared.
If the provider permits a query or appeal, use that process when there is credible evidence of an administrative or reporting discrepancy. However, a query should not replace an internal investigation. Even when the provider confirms an error in the report, the laboratory should record what happened and determine whether its own processes allowed confusion to occur.
Protect Patient Testing During the Investigation
An EQA failure may indicate a problem that affected routine specimens. The laboratory manager should promptly assess whether the same staff member, assay, reagent lot, instrument, or workflow was used for patient testing during the relevant period. The review should focus on risk and evidence rather than assuming that all routine results are unreliable.
Internal quality control trends are especially useful at this stage. Examine positive and negative control results, invalid rates, cycle threshold patterns where applicable, contamination indicators, equipment maintenance records, and reagent inventory. A sudden shift in control performance or an unusual increase in repeat testing can support the EQA finding.
If patient safety may be affected, the laboratory should follow its established escalation process. Depending on national policy and the severity of the issue, this may include notifying the laboratory director, biosafety or quality personnel, clinicians, disease-control authorities, or the EQA provider. Any review of potentially affected results must protect confidentiality and be documented carefully.
Investigate the Entire Testing Process
A root-cause investigation should follow the complete testing pathway: pre-analytical, analytical, and post-analytical. For TB testing, relevant points may include specimen receipt, acceptance criteria, labeling, storage temperature, decontamination, processing, reagent preparation, amplification or culture conditions, instrument operation, interpretation, and result reporting.
Interview the personnel involved while the event is still fresh. Ask them to describe what they actually did, rather than what the procedure says should happen. Compare that account with the current SOP, worksheets, training records, equipment logs, and quality control data. This often reveals practical workarounds, ambiguous instructions, or steps that are difficult to perform in the available setting.
Potential causes should be tested against evidence. For example, a reagent problem becomes more credible if other samples tested with the same lot showed unusual results. A transcription error is more plausible when the instrument record is correct but the submitted form is not. A competency issue may be suspected when errors recur after staff rotation or when a method has recently changed.
The GLI Quality Tool downloads provide practical materials that can help laboratories organize quality activities, review procedures, and document improvement work in a consistent manner.
Use Evidence to Classify the Root Cause
Laboratories can use a cause-and-effect diagram, five-whys analysis, fault tree, or a simple documented investigation form. The method matters less than ensuring that the review moves beyond the immediate error. “Staff made a mistake” is usually a symptom, not a sufficient root cause. The investigation should ask why the mistake was possible and why existing controls did not detect it.
Common root-cause categories include:
- Personnel: insufficient training, unfamiliarity with the method, fatigue, unclear responsibilities, or lack of competency assessment.
- Methods: outdated SOPs, missing acceptance criteria, ambiguous interpretation rules, or deviations that were never formally approved.
- Materials: expired or poorly stored reagents, unsuitable controls, supply interruptions, or lot-to-lot variation.
- Equipment: calibration failure, maintenance gaps, temperature problems, software errors, or inadequate environmental conditions.
- Management system: weak document control, incomplete records, ineffective supervision, or failure to review quality indicators.
The response should distinguish a one-time event from a systemic failure. A single incorrect transcription may need targeted correction and verification. Repeated errors across EQA rounds, staff members, or instruments suggest a broader process problem requiring management review and possibly external technical support.
Plan and Verify Corrective Action
Corrective action should address the identified cause, assign responsibility, set a deadline, and define objective evidence of completion. Actions might include revising an SOP, retraining and reassessing staff, introducing a second-person verification step, replacing a reagent lot, servicing an instrument, improving temperature monitoring, or redesigning the result-reporting form.
The action should be specific enough to prevent vague closure. “Staff reminded” is weaker than “all staff will complete a practical competency assessment on result interpretation, with signed records, by a defined date.” Similarly, “equipment checked” should identify the instrument, the maintenance or calibration performed, and the acceptance criteria used.
Verification is essential. After corrective action, review internal QC, repeat testing where permitted, observe the workflow, conduct a focused audit, or examine the next EQA round. The laboratory should define in advance what result will demonstrate effectiveness. If the action does not resolve the problem, the investigation must be reopened rather than marked complete.
| Finding or pattern | Possible concern | Immediate review | Evidence that action worked |
|---|---|---|---|
| One transcription error | Reporting or verification weakness | Compare worksheets, instrument records, and submitted forms | Error-free second-person checks over a defined period |
| Unexpected result with one reagent lot | Reagent deterioration or lot variation | Review storage, expiry, QC trends, and other affected tests | Acceptable QC and results after replacement or lot verification |
| Repeated errors by one staff member | Competency or supervision gap | Observe technique and review training records | Successful practical reassessment and satisfactory monitored work |
| Similar failures across staff | Method, equipment, or system problem | Audit SOP, instrument, environment, and workflow | Stable QC, compliant observations, and improved EQA performance |
| Late or incomplete submission | Communication or process control issue | Trace deadlines, responsibilities, and approval steps | On-time complete submissions in subsequent rounds |
Document the Event and Share the Learning
A complete nonconformity record should describe the EQA finding, date of detection, affected test or process, immediate containment, investigation method, root cause, corrective action, responsible person, due date, and effectiveness review. Attach relevant evidence, such as QC charts, maintenance records, amended forms, training results, or correspondence with the provider.
Documentation should be factual and respectful. Assigning personal blame can discourage staff from reporting near misses and makes it harder to identify system weaknesses. A learning-focused culture encourages early escalation, which is especially important when a result could affect TB diagnosis, drug-resistance detection, or infection-control decisions.
The laboratory should also communicate lessons that apply beyond the original event. A revised instruction may need to be shared with all testing sites or shifts. A new equipment check may need to be added to the routine schedule. Trends from multiple EQA cycles should be presented during quality meetings and included in management review.
Build EQA Findings into Continual Improvement
EQA should be part of a recurring quality cycle rather than an isolated exercise. At the beginning of each round, confirm responsibilities, panel receipt procedures, storage requirements, testing timelines, result review, and submission authorization. After the report arrives, analyze performance indicators and compare current findings with previous rounds.
Useful indicators may include the percentage of acceptable EQA results, recurring error types, invalid or contaminated results, turnaround time, corrective-action completion, and the proportion of actions verified as effective. Tracking these measures helps the laboratory identify gradual deterioration before it becomes a serious failure.
Laboratories working in varied resource settings can scale the process to their capacity while preserving its essential elements: confirm, contain, investigate, correct, verify, and learn. A simple paper form and well-maintained log can be effective when electronic systems are unavailable. The goal is reliable control of risk, not complex paperwork.
Practical Actions for the Next EQA Cycle
- Assign one person to coordinate EQA receipt, testing, review, submission, and record retention.
- Use a standard investigation form for every unacceptable, invalid, late, or disputed result.
- Compare EQA findings with internal QC, maintenance records, staff competency, and reagent-lot data.
- Set a clear effectiveness check for each corrective action and record the evidence.
- Review recurring trends during quality meetings and update procedures when needed.
A laboratory demonstrates quality when it can detect an out-of-control result, respond without delay, and show that the underlying risk has been reduced. Each EQA exception is an opportunity to strengthen testing reliability, staff confidence, documentation, and patient protection.
Use the GLI Quality Tool’s phase-based guidance and downloadable resources to turn EQA findings into documented corrective action and sustained improvement. Access the materials, adapt the relevant checklists to your laboratory, and make the response to every unacceptable result part of routine quality practice.